Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream

JAAD Case Rep. 2024 Mar 6:47:1-3. doi: 10.1016/j.jdcr.2024.02.022. eCollection 2024 May.

Authors

Sophia S Tran¹, Benjamin Ungar¹, Patrick M Brunner¹

Affiliation

¹ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: eczema; perioral dermatitis; ruxolitinib; skin side effect; steroid side effect.

Publication types

Case Reports